Author Karen L. Chamberlain, RN, MSN, FNP-BC, is an instructor in the Associate Degree Nursing Program at the Milwaukee Area Technical College, Milwaukee, Wisconsin.
Homocysteine and cardiovascular disease: A review of current recommendations for screening and treatment
Version of Record online: 6 OCT 2005
Journal of the American Academy of Nurse Practitioners
Volume 17, Issue 3, pages 90–95, March 2005
How to Cite
Chamberlain, KarenL. (2005), Homocysteine and cardiovascular disease: A review of current recommendations for screening and treatment. Journal of the American Academy of Nurse Practitioners, 17: 90–95. doi: 10.1111/j.1041-2972.2005.0016.x
- Issue online: 6 OCT 2005
- Version of Record online: 6 OCT 2005
- cardiovascular disease;
- folic acid;
- B vitamins
To review the literature for, and provide advanced practice nurses (APNs) with, current recommendations for screening and treatment of hyperhomocysteinemia.
Medscape literature search of selected research studies and related journal articles.
While data from most epidemiologic studies support the argument that hyperhomocysteinemia is an independent risk factor for cardiovascular disease, the debate continues as to when screening and treating patients is appropriate. The consensus is that more randomized controlled trials are needed to further study the benefits of routine screening and the efficacy of treating hyperhomocysteinemia.
Implications for practice
Until the results of ongoing clinical trials are available, APNs should follow the American Heart Association guidelines for screening for elevated levels of homocysteine and continue to promote a well-balanced diet that includes foods rich in folic acid as part of health promotion through primary prevention.